Literature DB >> 2492103

Decrease in plasminogen activator correlates with synapse elimination during neonatal development of mouse skeletal muscle.

D Hantaï1, J S Rao, C Kahler, B W Festoff.   

Abstract

Previous studies have implicated proteases, acting extracellularly, in the mechanism of polyneuronal synapse elimination. Most studies have focused on mammalian, especially rodent, skeletal muscle, where retraction of subordinate nerve terminals occurs during a narrow time window 2-3 weeks after birth. To date no specific protease(s) has been detected that (i) coincides in time with maximal synapse elimination and (ii) is known to act extracellularly on specific extracellular matrix proteins. In previous studies of denervation in adult mouse muscle, rapid activation of urokinase-type plasminogen activator, a neutral serine protease, was detected. This enzyme, by activation of plasminogen to plasmin, specifically degrades matrix components such as fibronectin, type IV collagen, and laminin in muscle. We now present evidence for an initial increase and subsequent decrease in soluble urokinase-type PA--and, to a lesser extent, tissue PA--in developing muscle, suggesting postnatal developmental regulation of these enzymes during the period of maximal synapse elimination. Although considerably higher in specific activity, membrane-bound PA activity followed the wave of synapse elimination, possibly indicating a longer half-life of membrane-bound enzyme(s).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2492103      PMCID: PMC286465          DOI: 10.1073/pnas.86.1.362

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Elimination of polyneuronal innervation in a fast muscle of normal and dystrophic mice.

Authors:  J Dangain; G Vrbová
Journal:  J Physiol       Date:  1983-09       Impact factor: 5.182

Review 2.  Development of the neuromuscular junction: inductive interactions between cells.

Authors:  M J Dennis
Journal:  Annu Rev Neurosci       Date:  1981       Impact factor: 12.449

Review 3.  Motor nerve sprouting.

Authors:  M C Brown; R L Holland; W G Hopkins
Journal:  Annu Rev Neurosci       Date:  1981       Impact factor: 12.449

4.  A single-vial biphasic liquid extraction assay for choline acetyltransferase using [3H]choline.

Authors:  J B Rand; C D Johnson
Journal:  Anal Biochem       Date:  1981-09-15       Impact factor: 3.365

5.  The effect of acetylcholine on the function and structure of the developing mammalian neuromuscular junction.

Authors:  R A O'Brien; A J Ostberg; G Vrbová
Journal:  Neuroscience       Date:  1980       Impact factor: 3.590

6.  Development of neuromuscular junctions in rat embryos.

Authors:  M J Dennis; L Ziskind-Conhaim; A J Harris
Journal:  Dev Biol       Date:  1981-01-30       Impact factor: 3.582

7.  Neuromuscular junction macromolecules in the pathogenesis of amyotrophic leteral sclerosis.

Authors:  B W Festoff
Journal:  Med Hypotheses       Date:  1980-02       Impact factor: 1.538

8.  Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex.

Authors:  E G Levin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

9.  Inhibition of a plasminogen activator from oncogenic virus-transformed mouse cells by rabbit antibodies against the enzyme.

Authors:  K Danø; L S Nielsen; V Møller; M Engelhart
Journal:  Biochim Biophys Acta       Date:  1980-06-05

10.  A study of proteases and protease-inhibitor complexes in biological fluids.

Authors:  A Granelli-Piperno; E Reich
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

View more
  8 in total

1.  Rapid neural regulation of muscle urokinase-like plasminogen activator as defined by nerve crush.

Authors:  D Hantaï; J S Rao; B W Festoff
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

2.  Protease nexin I (PNI) in mouse brain is expressed from the same gene as in seminal vesicle.

Authors:  B A Citron; K T Ratzlaff; I V Smirnova; B W Festoff
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

3.  Fast and slow rat muscles degenerate and regenerate differently after whole crush injury.

Authors:  Y Bassaglia; J Gautron
Journal:  J Muscle Res Cell Motil       Date:  1995-08       Impact factor: 2.698

4.  Expression of neuroserpin, an inhibitor of tissue plasminogen activator, in the developing and adult nervous system of the mouse.

Authors:  S R Krueger; G P Ghisu; P Cinelli; T P Gschwend; T Osterwalder; D P Wolfer; P Sonderegger
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

5.  Neuroserpin, an axonally secreted serine protease inhibitor.

Authors:  T Osterwalder; J Contartese; E T Stoeckli; T B Kuhn; P Sonderegger
Journal:  EMBO J       Date:  1996-06-17       Impact factor: 11.598

6.  Increased levels of plasminogen activator inhibitor-1 (PAI-1) in human brain tumors.

Authors:  J S Rao; A Rayford; R A Morantz; B W Festoff; R Sawaya
Journal:  J Neurooncol       Date:  1993-09       Impact factor: 4.130

7.  A serine protease inhibitor, protease nexin I, rescues motoneurons from naturally occurring and axotomy-induced cell death.

Authors:  L J Houenou; P L Turner; L Li; R W Oppenheim; B W Festoff
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

Review 8.  The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting Therapies.

Authors:  Barry W Festoff; Chris Dockendorff
Journal:  Biomolecules       Date:  2021-10-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.